• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者更正：脂质体伊立替康对晚期胰腺腺癌治疗的影响：台湾队列的真实世界经验。

Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort.

作者信息

Su Yung-Yeh, Chiang Nai-Jung, Tsai Hui-Jen, Yen Chia-Jui, Shan Yan-Shen, Chen Li-Tzong

机构信息

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.

Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Sci Rep. 2020 Nov 13;10(1):20199. doi: 10.1038/s41598-020-77250-4.

DOI:10.1038/s41598-020-77250-4
PMID:33188263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666201/
Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

摘要

本文的一个修订版本已发表，可通过本文顶部的链接获取。

相似文献

1
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort.作者更正：脂质体伊立替康对晚期胰腺腺癌治疗的影响：台湾队列的真实世界经验。
Sci Rep. 2020 Nov 13;10(1):20199. doi: 10.1038/s41598-020-77250-4.
2
Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.作者更正：没药酸脂质体制剂提高了聚乙二醇化脂质体阿霉素对小鼠结肠癌的治疗效果。
Sci Rep. 2020 Feb 27;10(1):3965. doi: 10.1038/s41598-020-60918-2.
3
Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.作者更正：PD-1/PD-L1抑制剂治疗晚期非小细胞肺癌的真实世界证据及临床观察
Sci Rep. 2020 Jan 27;10(1):1525. doi: 10.1038/s41598-020-58487-5.
4
Author Correction: Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.作者更正：单细胞RNA测序揭示胰腺导管腺癌的肿瘤内异质性和恶性进展
Cell Res. 2019 Sep;29(9):777. doi: 10.1038/s41422-019-0212-1.
5
Author Correction: Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study.作者更正：银屑病患者终末期肾病风险：基于全国人群队列研究的真实世界数据。
Sci Rep. 2020 Feb 5;10(1):2284. doi: 10.1038/s41598-020-59024-0.
6
Author Correction: Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population.作者更正：台湾慢性肾脏病患者群体中体重指数与肾功能恶化的关系。
Sci Rep. 2020 Feb 13;10(1):2822. doi: 10.1038/s41598-020-59783-w.
7
Author Correction: Investigating the relationship between district-level socioeconomic status and individual obesity in Taiwanese adolescents: A large-scale cross-sectional analysis.作者更正：探究台湾青少年地区层面社会经济地位与个体肥胖之间的关系：一项大规模横断面分析。
Sci Rep. 2020 Feb 6;10(1):2387. doi: 10.1038/s41598-020-59136-7.
8
Author Correction: Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population.作者更正：血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单药治疗可延缓台湾慢性肾脏病患者肾功能恶化。
Sci Rep. 2020 Apr 15;10(1):6631. doi: 10.1038/s41598-020-63162-w.
9
Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan.比较接受脂质体伊立替康治疗的转移性胰腺导管腺癌患者的真实世界证据。
Ther Adv Med Oncol. 2020 Aug 17;12:1758835920944052. doi: 10.1177/1758835920944052. eCollection 2020.
10
Author Correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.
Sci Rep. 2020 Jul 28;10(1):12950. doi: 10.1038/s41598-020-69880-5.